Genovis AB (Sweden) Market Value

GENO Stock  SEK 26.25  0.35  1.32%   
Genovis AB's market value is the price at which a share of Genovis AB trades on a public exchange. It measures the collective expectations of Genovis AB investors about its performance. Genovis AB is selling for under 26.25 as of the 10th of August 2025; that is 1.32% down since the beginning of the trading day. The stock's last reported lowest price was 25.5.
With this module, you can estimate the performance of a buy and hold strategy of Genovis AB and determine expected loss or profit from investing in Genovis AB over a given investment horizon. Check out Genovis AB Correlation, Genovis AB Volatility and Genovis AB Alpha and Beta module to complement your research on Genovis AB.
Symbol

Please note, there is a significant difference between Genovis AB's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genovis AB is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genovis AB's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Genovis AB 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Genovis AB's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Genovis AB.
0.00
05/12/2025
No Change 0.00  0.0 
In 3 months and 1 day
08/10/2025
0.00
If you would invest  0.00  in Genovis AB on May 12, 2025 and sell it all today you would earn a total of 0.00 from holding Genovis AB or generate 0.0% return on investment in Genovis AB over 90 days. Genovis AB is related to or competes with Ascendis Pharma, Alligator Bioscience, Bavarian Nordic, Bonesupport Holding, Smart Eye, Surgical Science, and XSpray Pharma. Genovis AB develops, produces, and sells tools for developing new medications and diagnostics for customers in the medic... More

Genovis AB Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Genovis AB's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Genovis AB upside and downside potential and time the market with a certain degree of confidence.

Genovis AB Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Genovis AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Genovis AB's standard deviation. In reality, there are many statistical measures that can use Genovis AB historical prices to predict the future Genovis AB's volatility.
Hype
Prediction
LowEstimatedHigh
24.0326.2528.47
Details
Intrinsic
Valuation
LowRealHigh
22.1824.4026.62
Details
Naive
Forecast
LowNextHigh
24.0826.3028.52
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
25.3827.3729.37
Details

Genovis AB Backtested Returns

Currently, Genovis AB is very steady. Genovis AB holds Efficiency (Sharpe) Ratio of 0.0545, which attests that the entity had a 0.0545 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Genovis AB, which you can use to evaluate the volatility of the firm. Please check out Genovis AB's Risk Adjusted Performance of 0.0681, downside deviation of 2.48, and Market Risk Adjusted Performance of 0.4622 to validate if the risk estimate we provide is consistent with the expected return of 0.12%. Genovis AB has a performance score of 4 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.4, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Genovis AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding Genovis AB is expected to be smaller as well. Genovis AB right now retains a risk of 2.22%. Please check out Genovis AB standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to decide if Genovis AB will be following its current trending patterns.

Auto-correlation

    
  0.02  

Virtually no predictability

Genovis AB has virtually no predictability. Overlapping area represents the amount of predictability between Genovis AB time series from 12th of May 2025 to 26th of June 2025 and 26th of June 2025 to 10th of August 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Genovis AB price movement. The serial correlation of 0.02 indicates that only 2.0% of current Genovis AB price fluctuation can be explain by its past prices.
Correlation Coefficient0.02
Spearman Rank Test-0.44
Residual Average0.0
Price Variance0.96

Genovis AB lagged returns against current returns

Autocorrelation, which is Genovis AB stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Genovis AB's stock expected returns. We can calculate the autocorrelation of Genovis AB returns to help us make a trade decision. For example, suppose you find that Genovis AB has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Genovis AB regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Genovis AB stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Genovis AB stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Genovis AB stock over time.
   Current vs Lagged Prices   
       Timeline  

Genovis AB Lagged Returns

When evaluating Genovis AB's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Genovis AB stock have on its future price. Genovis AB autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Genovis AB autocorrelation shows the relationship between Genovis AB stock current value and its past values and can show if there is a momentum factor associated with investing in Genovis AB.
   Regressed Prices   
       Timeline  

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Genovis Stock Analysis

When running Genovis AB's price analysis, check to measure Genovis AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovis AB is operating at the current time. Most of Genovis AB's value examination focuses on studying past and present price action to predict the probability of Genovis AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovis AB's price. Additionally, you may evaluate how the addition of Genovis AB to your portfolios can decrease your overall portfolio volatility.